MEDNAX Inc (MD) is Reiterated by Mizuho to Buy, Raises Price Target to $ 79

MEDNAX Inc (MD) was Reiterated by Mizuho to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 79 from a previous price target of $75 . Mizuho advised their investors in a research report released on Apr 29, 2016.

Many Wall Street Analysts have commented on MEDNAX Inc. Shares were Reiterated by Stifel on Mar 8, 2016 to “Buy” and Lowered the Price Target to $ 76 from a previous price target of $81 .MEDNAX Inc was Downgraded by Susquehanna to ” Neutral” on Mar 7, 2016.

On the company’s financial health, MEDNAX Inc reported $1.13 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Feb 4, 2016. Analyst had a consensus of $1.12. The company had revenue of $741.70 million for the quarter, compared to analysts expectations of $747.86 million. The company’s revenue was up 14.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.89 EPS.

MEDNAX Inc opened for trading at $71.96 and hit $72.94 on the upside on Wednesday, eventually ending the session at $72.94, with a gain of 1.32% or 0.95 points. The heightened volatility saw the trading volume jump to 9,03,516 shares. Company has a market cap of $6,842 M.

In a different news, on Mar 11, 2016, Md Pascal J Goldschmidt, (director) sold 3,100 shares at $65.00 per share price. According to the SEC, on Sep 10, 2015, Cesar L Alvarez (director) sold 10,668 shares at $81.00 per share price. On Aug 28, 2015, Roger Md Medel (Chief Executive Officer) sold 100,000 shares at $80.27 per share price, according to the Form-4 filing with the securities and exchange commission.

MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.


Leave a Reply

MEDNAX Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on MEDNAX Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.